GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Consolidated Net Profit | ₹1,212 Cr | ₹997 Cr | ₹773 Cr | ₹773 Cr |
What is the latest Consolidated Net Profit of GLAND PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹1,212 Cr |
Mar2022 | ₹997 Cr |
Mar2021 | ₹773 Cr |
Mar2020 | ₹773 Cr |
How is Consolidated Net Profit of GLAND PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹1,212 Cr | 21.54 | |
Mar2022 | ₹997 Cr | 29.00 | |
Mar2021 | ₹773 Cr | 0.00 | |
Mar2020 | ₹773 Cr | - |
Compare Consolidated Net Profit of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹27,732.2 Cr | -1% | -6.6% | 25.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -1% |
-6.6% |
25.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses